Free Initial Consultation

Call 1-866-428-2529

Xeljanz and Xeljanz XR

Your Rheumatoid Arthritis Drug Could Be The Cause of Your Suffering


AVA Law Group is dedicated to supporting those struggling with injuries caused by Xeljanz and Xeljanz XR. We'll help you seek justice for your suffering.

Get your free case evaluation today.

Xeljanz Users Are at Risk of Severe Health Complications

Breaking news from the FDA reveals that Xeljanz or Xeljanz XR users have an increased risk of developing blood clots in the lungs or death. Xeljanz/Xeljanz XR have recently been found to increase patients' risk of pulmonary embolism and death, affirmed by both the FDA and EMA.

Recent Posts

Student Sexual Abuse Silenced by Ohio State University for Decades: 180 Victims Accounted

Student Sexual Abuse Silenced by Ohio State University for Decades: 180 Victims Accounted May 20, 2019 Recent reports state an athletic doctor at Ohio State University sexually assaulted nearly 180 male students under his care between 1978 and 1998. Dr. Richard Strauss, who died in 2005, retired with emeritus status despite the widespread known and […]

Read More


In a postmarketing study of Xeljanz (tofacitinib), researchers discovered the popular rheumatoid arthritis drug increased risk of blood clots in the lungs. These blood clots in the lungs could potentially lead to a pulmonary embolism or death for Xeljanz users

According to the study, patients taking 10mg of Xeljanz twice daily for rheumatoid arthritis were at a significantly increased risk of developing blood clots and dying than users taking the same dose for ulcerative colitis. This mandatory ongoing safety trial is used to determine the safety of taking increased doses of Xeljanz. On February 25, 2019, the FDA alerted the public about the results of the required safety clinical trial, verifying Xeljanz manufacturer Pfizer Pharmaceutical Company’s results.
Pfizer announced on February 19, 2019 the devastating results of the safety trial, and assures that patients involved in the safety trial were placed back on the 5mg dosage of Xeljanz. This occurred after the FDA issued their February 25 safety issue. Along with discovering the increased risk of blood clots in the lungs and death, the clinical trial revealed that patients taking Xeljanz were also at an increased risk for serious infections.
Pfizer advises if you develop an infection while taking Xeljanz, your treatment should be halted until the infection is under control.

Xeljanz-Caused Infections Include:

Invasive fungal infections
Bacterial and viral infection that resulted in hospitalizations and deaths. 


Xeljanz (tofacitinib) was approved by the FDA in 2012 to treat rheumatoid arthritis in adults. Rheumatoid arthritis (RA), an autoimmune disorder that causes inflammation of the joints, impacts about 1% of the population. People struggling with RA experience pain, swelling, and loss of joint function. Typically tofacitinib is prescribed to patients with RA who do not react well to methotrexate, an alternate medicine used to treat rheumatoid arthritis. 

Xeljanz treats rheumatoid arthritis by blocking the activity of specific enzymes in the body that impact immune system function. The FDA approved Xeljanz and Xeljanz XR for treating active psoriatic arthritis (PsA) in December 2017. That approval expanded May 2018 to include using Xeljanz and Xeljanz XR to treat moderate to severe active ulcerative colitis, as well.

Patients experiencing the following symptoms from taking tofacitinib should seek medical attention immediately:

Blood clot in the lungs
Sudden shortness of breath or difficulty breathing
Chest pain or pain in your back
Coughing up blood
Excessive sweating
Clammy or bluish colored skin.
The European Medicines Agency (EMA) backed up the FDA’s findings, as well, in their press release on March 20. Like the FDA, the EMA warned Earuopean healthcare professionals to not go over the recommended dose of Xeljanz due to increased risk of blood clots in the lungs. 

Though Pfizer and the FDA announced that they plan on reassessing Xeljanz dosage levels and infection warnings presented in the clinical trial, thousands could be impacted by the misinformed prescription information. If you or someone you care about has been injured while taking Xeljanz, you may be entitled to legal compensation through a defective product lawsuit. 

Through our network of continual communication, concerned representatives, and expert lawyers, we go the extra mile to ensure your peace of mind. To AVA Law Group, Inc., you aren't just another number! Sign up today for your free case evaluation and to start taking steps towards justice and healing. 

AVA Law Group is Here for You!

When you work with AVA Law Group, Inc., you put your trust in legal professionals with the expertise and experience to make walking through the legal process easy.


We’re available 24/7 to provide you with the information you need about case qualification.


We eliminate the confusion of filing a claim by working on your claim and, if necessary, connecting you with our many partner firms that fits your needs and will get you the best results.


We provide a team of attorney, paralegals, and case managers to clients at no upfront cost.


Sign up today for your free case evaluation!


Contact Us

1. We're on your side               
2. WE're available 24/7     
3. No fees unless you win
ATTORNEY ADVERTISEMENT: Not available in all states, Andrew Van Arsdale, supervising attorney is licensed only in CA, but associates with attorneys throughout the country, Principal office: 3667 Voltaire Street, San Diego, CA 92106. 

No representation is made that the quality of the legal services performed is greater than the quality of the legal services performed by other lawyers. AVA Law Group, Inc. not accepting cases in states where this advertising conflicts with laws or state rules. While AVA Law Group, Inc. maintains joint responsibility, most cases are referred to other attorneys for principal responsibility. 
© Copyright 2019